Management of 10-Year Waxing-and-Waning Dyspepsia Without Alarm Features
In a patient with a 10-year history of waxing-and-waning dyspeptic symptoms who declines endoscopy and has no alarm features, you should diagnose functional dyspepsia (FD) clinically and proceed directly with H. pylori testing followed by eradication therapy if positive, then empirical proton pump inhibitor (PPI) therapy if symptoms persist. 1
Diagnostic Approach Without Endoscopy
The 2022 British Society of Gastroenterology guidelines explicitly support diagnosing FD without endoscopy in the absence of alarm symptoms. You can confidently diagnose FD when bothersome epigastric pain or burning, early satiation, and/or postprandial fullness have been present for greater than 8 weeks without alarm features. 1 The chronic, waxing-and-waning 10-year history actually strengthens this clinical diagnosis, as most patients with dyspepsia will have FD as the underlying cause after investigation.
When Endoscopy Can Be Deferred
The guidelines are clear that urgent endoscopy is only warranted in patients ≥55 years with weight loss, or those >40 years from high gastric cancer risk areas or with family history of gastro-oesophageal cancer. 1 Non-urgent endoscopy should be considered in patients ≥55 years with treatment-resistant dyspepsia or with raised platelet count, nausea, or vomiting. 1
Critical caveat: If your patient is ≥55 years old, you should strongly reconsider the need for at least non-urgent endoscopy, especially if symptoms prove treatment-resistant. The 10-year history provides some reassurance against malignancy, but age remains the dominant risk factor.
Stepwise Treatment Algorithm
Step 1: H. pylori Testing and Eradication
- Perform non-invasive H. pylori testing (urea breath test or stool antigen test preferred) 2
- If positive, provide eradication therapy 1, 2
- This approach is supported by high-quality evidence and may prevent future gastric adenocarcinoma 2
- You do NOT need to confirm successful eradication unless the patient has increased gastric cancer risk 1
Step 2: Empirical PPI Therapy
- If H. pylori negative OR symptoms persist after eradication, prescribe empirical PPI therapy for 4-8 weeks 1, 2
- This recommendation is based on strong evidence (high quality) 1
- Standard-dose PPI is appropriate; higher doses should not be pursued 3
Step 3: Tricyclic Antidepressants for Refractory Symptoms
- If symptoms fail to respond adequately to PPI therapy, add a tricyclic antidepressant 1, 3
- Continue for 6-12 months in responders 4
- This is particularly effective for epigastric pain syndrome (EPS) subtype 3
Step 4: Consider Prokinetics (with caution)
- Acotiamide (acetylcholinesterase inhibitor) is first-line prokinetic in some guidelines 5
- Other prokinetics (dopamine antagonists, 5-HT4 agonists) show limited efficacy but could be tried in postprandial distress syndrome (PDS) subtype 1, 3
- Important pitfall: Prokinetics have limited availability in some countries and risk of serious side effects 4
Step 5: Psychological Therapy
- Offer cognitive behavioral therapy for patients who fail to respond to drug treatments 1, 3
- This addresses the gut-brain axis dysfunction underlying FD 1
Essential Patient Communication
Establish an empathic relationship and explain that FD is a disorder of gut-brain interaction, not a psychological problem or "all in their head." 1 Discuss how the gut-brain axis is impacted by diet, stress, and emotional responses to symptoms. This communication may reduce healthcare utilization and improve quality of life. 1
The natural history of FD includes waxing and waning symptoms—which perfectly describes this patient's 10-year course—and this should be normalized for the patient. 1
Additional Testing Considerations
- Perform full blood count if patient is ≥55 years 1
- Check coeliac serology if overlapping IBS-type symptoms are present 1
- Do NOT routinely perform gastric emptying testing or 24-hour pH monitoring 1
When to Refer to Gastroenterology
Referral is appropriate when there is diagnostic doubt, severe symptoms, refractoriness to first-line treatments, or if the patient specifically requests specialist opinion. 1 Given the 10-year history and patient's refusal of endoscopy, referral may be reasonable if symptoms remain refractory after completing the treatment algorithm above, though endoscopy would still not be mandatory if alarm features remain absent.
The evidence supporting most FD management beyond H. pylori testing and PPI therapy is low-quality 4, but the algorithmic approach above represents the best available guidance from the most recent high-quality guidelines.